The risk of AVM rupture was evaluated from the A Randomized demo of Unruptured Brain Arteriovenous malformations (ARUBA) trial. This study disclosed a lessened risk of stroke and mortality in sufferers managed conservatively compared to sufferers who underwent interventional therapy.[thirteen]  The ARUBA demo compared health-related management alone to health care https://www.sgvascularctr.com/service/vascular-malformations/